Focus: Ocular Instruments is a specialized biotechnology company focused on ocular devices and ophthalmic therapeutics, with deep roots dating back to 1966. The company operates in the narrow but clinically critical ophthalmology segment.
Profile data last refreshed 21h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Ocular Instruments to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Sole marketed product with extended patent protection until 2041, representing the company's core revenue driver and clinical focus.
Help build intelligence for Ocular Instruments
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ocular Instruments's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
No open positions listed yet.
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo